HBV-ADV311

N/A

Report date: 2025/12/12 17:32:42

Base Information

Drug NameHBV-ADV311
Drug Alias Nametherapeutic DNA vaccine (Beijing Advaccine Biotechnology)therapeutic vaccine (Beijing Advaccine Biotechnology)HBV-ADV311
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Aidi Weixin Biotechnology Company
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Aidi Weixin Biotechnology Company
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A